Age at onset and the risk of proliferative retinopathy in type 1 diabetes

Diabetes Care

Volumn 33, Issue 6, 2010, Pages 1315-1319

  Hietala, Kustaa ^a,b   Harjutsalo, Valma ^a,b,c   Forsblom, Carol ^a,b   Summanen, Paula ^a   Groop, Per Henrik ^a,b,d  

^a FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c National Institute for Health and Welfare   (Finland)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHILD; CLINICAL TRIAL; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FINLAND; HAZARD RATIO; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTICENTER STUDY; ONSET AGE; OPHTHALMOSCOPY; PRESCHOOL CHILD; PROGNOSIS; PROLIFERATIVE RETINOPATHY; RISK FACTOR; SCHOOL CHILD; TREATMENT DURATION; AGE DISTRIBUTION; NEWBORN; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 77956080098     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-2278     Document Type: Article

References (25)

1. Klein R. The epidemiology of diabetic retinopathy: findings from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Int Ophthalmol Clin 1987;27:230-238
2. Deckert T, Simonsen SE, Poulsen JE. Prognosis of proliferative retinopathy in juvenilediabetics. Diabetes1967;16:728-733
3. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII. The twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008;115:1859-1868
4. Rossing K, Jacobsen P, Rossing P, Lauritzen E, Lund-Andersen H, Parving HH. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy. Diabetes Care 1998;21:2007-2015
5. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000;342:381-389
6. Hietala K, Forsblom C, Summanen P, Groop PH, FinnDiane Study Group. Heritability of proliferative diabetic retinopathy. Diabetes 2008;57:2176-2180
7. Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, LaPorte RE, Drash AL. Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 1989;12:686-693 (Pubitemid 19284091)
8. Donaghue KC, Fairchild JM, Craig ME, Chan AK, Hing S, Cutler LR, Howard NJ, Silink M. Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care 2003;26:1224-1229
9. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371:1777-1782
10. Fagerudd J, Forsblom C, Pettersson-Fernholm K, Groop PH, FinnDiane Study Group. Implementation of guidelines for the prevention of diabetic nephropathy. Diabetes Care 2004;27:803-804
11. Madsbad S, Alberti KG, Binder C, Burrin JM, Faber OK, Krarup T, Regeur L. Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. Br Med J 1979;2:1257-1259 (Pubitemid 10205150)
12. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL 3rd, Knatterud GL. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 1998;39:233-252
13. Bergstralh E. SAS macro: comprisk. Department of Biostatistics, Mayo Clinic College of Medicine, Rochester, MN, USA 2004
14. Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005;294:1782-1787
15. Wysocki T, Harris MA, Wilkinson K, Sadler M, Mauras N, White NH. Self-management competence as a predictor of outcomes of intensive therapy or usual care in youth with type 1 diabetes. Diabetes Care 2003;26:2043-2047
16. Acerini CL, Williams RM, Dunger DB. Metabolic impact of puberty on the course of type 1 diabetes. Diabetes Metab 2001;27:S19-S25
17. Sherry NA, Tsai EB, Herold KC. Natural history of β-cell function in type 1 diabetes. Diabetes 2005;54(Suppl. 2):S32-S39 (Pubitemid 43343329)
18. Kordonouri O, Danne T, Enders I, Weber B. Does the long-term clinical course of type I diabetes mellitus differ in patients with prepubertal and pubertal onset? Results of the Berlin Retinopathy Study. Eur J Pediatr 1998;157:202-207
19. Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M. A comparison of childhood and adult type I diabetes mellitus. N Engl J Med 1989;320:881-886
20. Steffes MW, Sibley S, Jackson M, Thomas W. β-Cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 2003;26:832-836
21. Wong J, Molyneaux L, Constantino M, Twigg SM, Yue DK. Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care 2008;31:1985-1990
22. Hutchinson A, McIntosh A, Peters J, O'Keeffe C, Khunti K, Baker R, Booth A. Effectiveness of screening and monitoring tests for diabetic retinopathy - a systematic review. Diabet Med 2000;17:495-506
23. Retinopathy Working Party. A protocol for screening for diabetic retinopathy in Europe. Diabet Med 1991;8:263-267
24. Virtamo T, Summanen P, Tuomilehto J, Laatikainen L. Diabetic retinopathy and visual impairment in juvenile onset diabetics in Finland (Abstract). Diabetes Metab 2001;27(Suppl. 2):2S14
25. Wong TY, Mwamburi M, Klein R, Larsen M, Flynn H, Hernandez-Medina M, Ranganathan G, Wirostko B, Pleil A, Mitchell P. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care 2009;32:2307-2313